| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | 2 | 2 |
| total | individual payouts | |
|---|---|---|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 439.91 | 333.77 | 361.02 | 332.57 |
| Receivables | 80.56 | 26.91 | 26.17 | 86.66 |
| Inventory | 10.92 | 27.49 | 26.56 | 24.64 |
| Other | — | — | — | — |
| 554.51 | 420.15 | 450.09 | 466.14 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 3.26 | 12.07 | 13.36 | 16.27 |
| ST’ Debt | — | 2.40 | — | — |
| Other | 10.79 | 1.55 | 1.59 | 53.58 |
| 27.64 | 49.64 | 49.04 | 97.83 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡ | ‡‡‡ | ‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 54.24 | 114.56 | — | — |
—
|
| ’25 | 124.42 | 51.24 | 59.45 | 50.13 |
285.23
|
| ’24 | 24.32 | 25.84 | 23.31 | 48.84 |
122.31
|
| ’23 | 14.80 | 7.90 | 10.08 | 92.31 |
125.10
|
| ’22 | 13.51 | 16.72 | 15.88 | 13.12 |
59.22
|
| ’21 | 5.80 | 17.40 | 1.58 | 63.26 |
88.05
|
| ’20 | 3.82 | 2.12 | 19.47 | 4.38 |
29.78
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 3.40 | 3.90 | — | — |
—
|
| ’25 | 2.43 | 50.12 | 9.55 | 13.15 |
75.24
|
| ’24 | 54.84 | 16.14 | (0.59) | (20.26) |
50.12
|
| ’23 | (4.35) | (14.77) | 1.16 | (4.54) |
(22.51)
|
| ’22 | (3.16) | (14.39) | 3.96 | (23.74) |
(37.34)
|
| ’21 | (6.12) | (1.91) | (1.25) | 22.60 |
13.33
|
| ’20 | (2.21) | (4.93) | 12.69 | (25.17) |
(19.62)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (5.96) | (1.89) | — | — |
—
|
| ’25 | 0.34 | 47.91 | 3.49 | 6.82 |
58.55
|
| ’24 | 54.57 | (135.73) | (7.83) | (23.55) |
(112.54)
|
| ’23 | (4.43) | (14.83) | 1.15 | (10.58) |
(28.69)
|
| ’22 | (3.20) | (19.77) | 3.81 | (23.92) |
(43.07)
|
| ’21 | (17.15) | (1.92) | (3.27) | 14.58 |
(7.76)
|
| ’20 | (8.15) | (12.92) | 12.66 | (25.19) |
(33.60)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.16) | 0.00 | — | — |
—
|
| ’25 | 0.25 | (0.03) | (0.03) | 0.04 |
0.22
|
| ’24 | 0.00 | (0.08) | (0.14) | (0.14) |
(0.36)
|
| ’23 | (0.07) | (0.36) | (0.03) | 0.75 |
0.58
|
| ’22 | (1.61) | (1.44) | 0.02 | (0.50) |
(3.13)
|
| ’21 | (2.81) | 0.23 | 0.86 | 0.45 |
1.91
|
| ’20 | (0.24) | 0.09 | 0.32 | 1.33 |
1.54
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 3.30 | 3.43 | 3.65 | 2.70 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 5.40 | 4.66 | 5.74 | 4.53 | — | — | — |
High Price
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 263 | 170 | 1,036 | 986 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.23 | 0.74 | 0.12 | 0.29 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 59.22 | 125.10 | 122.31 | 285.23 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 36.87% | 57.77% | 24.24% | 29.62% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (127.15) | 67.43 | (38.15) | 31.31 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (214.70%) | 53.90% | (31.19%) | 10.98% | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (110.94) | 68.93 | (34.70) | 24.47 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.60 | 14.73 | 34.56 | 45.08 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.39 | 1.66 | 1.23 | 2.96 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | (3.13) | 0.73 | (0.36) | 0.23 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.88) | (0.30) | 0.51 | 0.78 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.13) | (0.08) | (1.64) | (0.17) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.01) | (0.38) | (1.13) | 0.61 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.81 | 7.83 | 5.57 | 6.07 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.46 | 75.30 | 99.21 | 96.29 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.00 | 8.00 | 0.00 | 16.26 | ‡‡‡‡‡ | — | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.86 | 2.36 | 3.52 | 1.26 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.63 | 0.50 | 0.78 | 0.62 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (2.58) | (1.06) | 1.35 | 0.21 | ‡‡‡ | ‡‡‡ | — |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.99 | 3.95 | (1.40) | 1.58 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (37.34) | (22.51) | 50.12 | 75.24 | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (5.73) | (6.19) | (162.67) | (16.69) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (43.07) | (28.69) | (112.54) | 58.55 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 340.78 | 526.88 | 370.51 | 401.05 | — | — | — |
Working Cap'
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 63.88 | 10.53 | 68.90 | 59.50 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (322.26) | (429.38) | (264.86) | (301.52) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 289.25 | 589.61 | 552.62 | 584.03 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (20.76%) | 9.88% | (5.19%) | 2.84% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡ | 0.00% | 8.17% | (7.15%) | 1.42% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (38.02%) | 12.84% | (6.31%) | 3.82% | — | — | — |
ROE
|
Acacia Research Corporation (ACTG) thrives in the high-stakes world of intellectual property licensing and patent monetization, but its financials scream volatility: revenue has swung wildly from $153 million peaks in 2016 to a dismal $11 million trough in 2019, with recent years showing 111% surges followed by dips, tied to unpredictable litigation wins and settlements. Profit margins and EPS have mirrored this feast-or-famine pattern, soaring to triple-digit highs in boom years like 2020-2021 before plunging into deep losses, exacerbated by massive capex spikes and employee growth that slashed revenue per employee by 99%. Yet, forecasts tease a tantalizing 123% revenue jump to $273 million in 2025—before a 38% drop in 2026—raising questions about whether new deals can break the cycle.
What sets ACTG apart is its rock-solid balance sheet: a net cash position exceeding $220 million, ballooning working capital, and low PB ratios around 1x scream undervaluation amid the chaos. Recent insider buying by top execs adds a bullish whisper, while aggressive acquisitions fuel expansion but spark efficiency worries. Stock performance has decoupled from extremes, trading cheaply near historical lows despite stable 2024 revenue.
For risk-tolerant investors, this could be a speculative gem with 25% upside potential per analysts—but litigation flops, acquisition indigestion, and earnings whiplash demand tiny positions and steel nerves. Dive into the full analysis for the charts, ratios, and exact risks that could turn this cash-rich wildcard into your next big win (or wipeout).
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.